Immulabsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2020-01-30
Share capital
5,000.00 PLN
Registered address
ul. Józefa Marcika 6, 30-443 Kraków, Poland

Financials

Revenue history

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 29 days for 2021).

  • 202521/07/2026
  • 202428/06/2025
  • 202316/07/2024
  • 202224/06/2023
  • 202113/08/2022
  • 202021/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 3.26kMedianUSD 55.24kAverageUSD 2.70m
Net profit
This companyUSD 1.12kMedianUSD -1.27kAverageUSD -92.18k
Operating costs
This companyUSD 2.13kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 4.21kMedianUSD 133.19kAverageUSD 3.03m

Authorized Representatives

Tomasz Kozioł – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Jerzy Koziołage 70
25$337.6625%
Tomasz Koziołage 42
25$337.6625%
Jacek Międzobrodzkiage 72
25$337.6625%
Jacek Walczak
25$337.6625%

Jerzy Kozioł and Tomasz Kozioł hold a combined 50% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2020-04-28.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

Name
MedappS.A.
SkinlabP.S.A.
EIT Rawmaterials Clc Eastsp. z o.o.
COS LabP.S.A.
IntelliseqS.A.
Przedsiębiorstwo Wielobranżowe Genezasp. z o.o.
Medtransfersp. z o.o.
Oncotherics PolandS.A.
Fusiomicasp. z o.o.
Ncage TherapeuticsS.A.

Change history

DateEvent
2022-11-21Address change
2020-01-30Entered in the register

FAQ

Last updated: 2026-07-21